ImmuPharma (LON:IMM) Reaches New 52-Week Low at $6.30

Shares of ImmuPharma plc (LON:IMM) hit a new 52-week low during trading on Tuesday . The stock traded as low as GBX 6.30 ($0.08) and last traded at GBX 6.35 ($0.08), with a volume of 1156772 shares trading hands. The stock had previously closed at GBX 6.76 ($0.09).

The company’s 50-day moving average is GBX 7.33 and its 200 day moving average is GBX 8.11. The company has a debt-to-equity ratio of 12.36, a quick ratio of 2.59 and a current ratio of 2.68. The company has a market capitalization of £16.41 million and a PE ratio of -2.13.

About ImmuPharma (LON:IMM)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity, metabolism, anti-infectives, and cancer. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

See Also: What is the definition of market timing?

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.